The COVID Positive Pathway: a collaboration between public health agencies, primary care, and metropolitan hospitals in Melbourne.
Environment and public health
General medicine
Health services administration
Infectious diseases
Journal
The Medical journal of Australia
ISSN: 1326-5377
Titre abrégé: Med J Aust
Pays: Australia
ID NLM: 0400714
Informations de publication
Date de publication:
02 05 2022
02 05 2022
Historique:
revised:
30
11
2021
received:
05
08
2021
accepted:
09
12
2021
pubmed:
19
3
2022
medline:
4
5
2022
entrez:
18
3
2022
Statut:
ppublish
Résumé
To assess the capacity of the COVID Positive Pathway, a collaborative model of care involving the Victorian public health unit, hospital services, primary care, community organisations, and the North Western Melbourne Primary Health Network, to support people with coronavirus disease 2019 (COVID-19) isolating at home. Cohort study of adults in northwest Melbourne with COVID-19, 3 August - 31 December 2020. Demographic and clinical characteristics, and social and welfare needs of people cared for in the Pathway, by care tier level. Of 1392 people referred to the Pathway by the public health unit, 858 were eligible for enrolment, and 711 consented to participation; 647 (91%) remained in the Pathway until they had recovered and isolation was no longer required. A total of 575 participants (81%) received care in primary care, mostly from their usual general practitioners; 155 people (22%) received care from hospital outreach services, and 64 (9%) needed high tier care (hospitalisation). Assistance with food and other basic supplies was required by 239 people in the Pathway (34%). The COVID Positive Pathway is a feasible multidisciplinary, tiered model of care for people with COVID-19. About 80% of participants could be adequately supported by primary care and community organisations, allowing hospital services to be reserved for people with more severe illness or with risk factors for disease progression. The principles of this model could be applied to other health conditions if regulatory and funding barriers to information-sharing and care delivery by health care providers can be overcome.
Identifiants
pubmed: 35301714
doi: 10.5694/mja2.51449
pmc: PMC9115045
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
413-419Informations de copyright
© 2022 AMPCo Pty Ltd.
Références
Scand J Public Health. 2021 Nov;49(7):815-820
pubmed: 33550931
Ann Intern Med. 2021 Feb;174(2):192-199
pubmed: 33175567
Health Aff (Millwood). 2017 Oct 1;36(10):1705-1711
pubmed: 28971914
J Med Internet Res. 2021 Mar 9;23(3):e21064
pubmed: 33687341
Health Policy Technol. 2020 Dec;9(4):488-502
pubmed: 32874859
J Med Internet Res. 2021 Feb 10;23(2):e25518
pubmed: 33529157
Med J Aust. 2020 Aug;213(3):134-139
pubmed: 32677734
Health Aff (Millwood). 2020 Jun;39(6):936-941
pubmed: 32271627
Eur Heart J. 2020 Jun 1;41(32):3045-3054
pubmed: 32562486
BMJ. 2021 Jan 28;372:n129
pubmed: 33509801
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
BMJ Qual Saf. 2016 Dec;25(12):986-992
pubmed: 26369893
Global Health. 2021 Feb 22;17(1):22
pubmed: 33618688
Med J Aust. 2012 Nov 5;197(9):512-9
pubmed: 23121588
Lancet Infect Dis. 2020 Oct;20(10):1151-1160
pubmed: 32559451
Lancet Infect Dis. 2021 Jul;21(7):893-894
pubmed: 33743849